ArticleBioengineering & translational medicine2023

Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Weisong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.